The plutocrats of Wall Street now decides who lives and who dies.
The virus resides in the lungs and being a virus it destroys lung tissue when it replicates. Those that die suffocate and those that recover have permanent damage to their lungs.
June 25. 2013
By Phillip Ward
The new study (click here) -- the largest case series to date -- includes 47 cases (46 adults, 1 child) of confirmed MERS coronavirus (MERS-CoV) infections from Saudi Arabia between 1 September 2012, and 15 June 2013. By combining clinical records, lab results, and imaging findings with demographic data, the authors noted older patients, especially men, and patients with underlying medical conditions, tend to succumb to the disease....
Imaging findings at presentation in Saudi patients with MERS. A: Chest radiograph of a 61-year-old man, showing bilateral fine reticulonodular air-space opacities, increased vascular markings, and cardiomegaly. B: Chest radiograph of an 83-year-old man, showing right lung consolidation, right basal pleural thickening, and reticulonodular air-space opacities; rib fractures on the right are old. C: Chest radiograph of a 56-year-old man, showing extensive bilateral extensive diffuse and focal alveolar space opacities, with opacification of the left lower lobe. D: Chest radiograph of a 67-year-old man, showing extensive bilateral disease, with diffuse alveolar space densities, opacification, reticulonodular opacities, and bronchial wall thickening. E: Chest radiograph of a 49-year-old man, showing extensive bilateral mid and lower zone disease, with diffuse reticulonodular alveolar space opacities. A thoracic CT scan in the same patient (F) shows extensive bilateral opacities and ground-glass reticulonodular shadowing and bronchiolar wall thickening. All images courtesy of Lancet Infectious Diseases.
Nature Medicine 19, 1313–1317 doi:10.1038/nm.3362
Received Accepted Published online
The emergence of Middle East (click here) respiratory syndrome coronavirus (MERS-CoV) is of global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 deaths at the time of this article's publication. Therapeutic interventions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care, which, given the high case-fatality rate, is not highly effective. The rhesus macaque is the only known model organism for MERS-CoV infection, developing an acute localized to widespread pneumonia with transient clinical disease that recapitulates mild to moderate human MERS-CoV cases. The combination of interferon-α2b and ribavirin was effective in reducing MERS-CoV replication in vitro; therefore, we initiated this treatment 8 h after inoculation of rhesus macaques....
The CDC is working with the WHO. With budget cuts there isn't a robust response to the need for a virus before it does become a pandemic or worse.
It is a very incideous virus. It can survive initially without detection until the population of virus has done enough damage to cause shortness of breath. The virus needs a vaccine. Silent killers have a high capacity to cause many more deaths.
Fever OR symptoms of respiratory illness (not necessarily pneumonia; e.g., cough, shortness of breath) AND close contact with a confirmed MERS case while the case was ill.
The virus resides in the lungs and being a virus it destroys lung tissue when it replicates. Those that die suffocate and those that recover have permanent damage to their lungs.
June 25. 2013
By Phillip Ward
The new study (click here) -- the largest case series to date -- includes 47 cases (46 adults, 1 child) of confirmed MERS coronavirus (MERS-CoV) infections from Saudi Arabia between 1 September 2012, and 15 June 2013. By combining clinical records, lab results, and imaging findings with demographic data, the authors noted older patients, especially men, and patients with underlying medical conditions, tend to succumb to the disease....
Imaging findings at presentation in Saudi patients with MERS. A: Chest radiograph of a 61-year-old man, showing bilateral fine reticulonodular air-space opacities, increased vascular markings, and cardiomegaly. B: Chest radiograph of an 83-year-old man, showing right lung consolidation, right basal pleural thickening, and reticulonodular air-space opacities; rib fractures on the right are old. C: Chest radiograph of a 56-year-old man, showing extensive bilateral extensive diffuse and focal alveolar space opacities, with opacification of the left lower lobe. D: Chest radiograph of a 67-year-old man, showing extensive bilateral disease, with diffuse alveolar space densities, opacification, reticulonodular opacities, and bronchial wall thickening. E: Chest radiograph of a 49-year-old man, showing extensive bilateral mid and lower zone disease, with diffuse reticulonodular alveolar space opacities. A thoracic CT scan in the same patient (F) shows extensive bilateral opacities and ground-glass reticulonodular shadowing and bronchiolar wall thickening. All images courtesy of Lancet Infectious Diseases.
Received Accepted Published online
The emergence of Middle East (click here) respiratory syndrome coronavirus (MERS-CoV) is of global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 deaths at the time of this article's publication. Therapeutic interventions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care, which, given the high case-fatality rate, is not highly effective. The rhesus macaque is the only known model organism for MERS-CoV infection, developing an acute localized to widespread pneumonia with transient clinical disease that recapitulates mild to moderate human MERS-CoV cases. The combination of interferon-α2b and ribavirin was effective in reducing MERS-CoV replication in vitro; therefore, we initiated this treatment 8 h after inoculation of rhesus macaques....
The CDC is working with the WHO. With budget cuts there isn't a robust response to the need for a virus before it does become a pandemic or worse.
Summary (click here)
The Centers for Disease Control and Prevention (CDC) continues to work with the World Health Organization (WHO) and other partners to closely monitor Middle East Respiratory Syndrome Coronavirus (MERS-CoV) globally, including the cases of MERS-CoV infection recently reported by China and the Republic of Korea, to better understand the risks to public health. The purpose of this HAN Advisory is to provide updated guidance to state health departments and healthcare providers in the evaluation of patients for MERS-CoV infection, which have been revised in light of the current situation in the Republic of Korea. Healthcare providers and public health officials should maintain awareness of the need to consider MERS-CoV infection in ill persons who have recently traveled from countries in or near the Arabian Peninsula1 or in the Republic of Korea as outlined in the guidance below. Please disseminate this information to healthcare providers, especially infectious diseases specialists, intensive care physicians, internists, infection preventionists, and to emergency departments and microbiology laboratories.It is a very incideous virus. It can survive initially without detection until the population of virus has done enough damage to cause shortness of breath. The virus needs a vaccine. Silent killers have a high capacity to cause many more deaths.
Fever OR symptoms of respiratory illness (not necessarily pneumonia; e.g., cough, shortness of breath) AND close contact with a confirmed MERS case while the case was ill.
